PharmAthene was formed in 2001 to meet the critical needs of this Nation and its Allies by developing biological and chemical defense products. The Company is dedicated to the rapid development of important and novel biotherapeutics to address biological pathogens and chemicals that may be used as weapons of bioterror. More >>

Stock Quote

PIP (Common Stock) Exchange NYSE Amex (US Dollar) Price $1.33 Change (%)   0.03 (2.31%) Volume 240,048 Data as of 01/27/12 4:01 p.m. ET Minimum 20 minute delay Refresh quote

Webcasts

Date Title Duration 11/09/11   Q3 2011 Pharmathene Inc Earnings Conference Call 60 minutes 09/23/11   PharmAthene, Inc. Conference Call to Discuss Delaware Court of Chancery Decision 60 minutes 04/15/11   PharmAthene Inc. at BioCentury Future Leaders in the Biotech Industry Conference 60 minutes 03/28/11   2010 Year End Financial Results Conference Call 60 minutes 03/14/11   Pharmathene Inc at Roth Capital Partners OC Growth Stock Conference 60 minutes

What's New

2011 Form 10-K/A

Receive E-mail Alerts

Sign up to receive e-mail alerts whenever PharmAthene, Inc. posts new information to the site. Just enter your e-mail address and click Submit.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.